Clinical Trial Update: PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining ibuprofen for patent ductus arteriosus after premature birth and its relationship to tissue oxygenation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus After Premature Birth

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Patent Ductus Arteriosus After Premature Birth | Phase 4 | Status: UNKNOWN